|
Summary Information: Esperion Therapeutics Inc. Common Stock NASDAQ:ESPR |
[email protected] |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at Esperion is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.
__The following are links to various summary and news pages for __Esperion Therapeutics Inc. Common Stock [ ESPR ]. __Note: Some Links might not have information for the company. |
|